What is the Thermo Fisher Scientific Inc. stock price forecast?

Thermo Fisher Scientific Inc. is currently trading at $472.63. View real-time AI analysis on Alpha Lenz.

What is Thermo Fisher Scientific Inc. insider trading activity?

View the latest insider trading data for Thermo Fisher Scientific Inc. on Alpha Lenz.

What is Thermo Fisher Scientific Inc.'s P/E ratio?

Thermo Fisher Scientific Inc.'s P/E ratio is 26.6.

Thermo Fisher Scientific Inc.

NYSE · TMO

$472.63-1.09(-0.23%)Pre-market

Ask about Thermo Fisher Scientific Inc.'s future dividend policy...

Alpha Chat Insight

“Thermo Fisher Scientific Inc. trades at a P/E of 26.6 (premium valuation) with solid ROE of 13.0%.”

Ask for details →

Company Overview

Thermo Fisher Scientific Inc. is a global leader in providing analytical instruments, laboratory equipment, and life science solutions. The company serves a wide range of industries, including pharmaceuticals, biotechnology, clinical diagnostics, and research institutions. Thermo Fisher Scientific helps customers accelerate life sciences research, improve patient diagnostics, and develop life-changing therapies. Its product portfolio includes reagents, instruments, and consumables for biological research, diagnostics, and vaccine development. Operating in multiple sectors, such as healthcare and diagnostics, the company is renowned for its innovative technologies and comprehensive services. Thermo Fisher Scientific plays a crucial role in supporting advancements across various scientific fields.

CEOMr. Marc N. Casper

Websitehttps://www.thermofisher.com

SectorHealthcare

IndustryDiagnostics & Research

Employees125,000

Company Statistics

FY 2025

Profile

$178.18BMarket Cap

$44.56BRevenue

0.00Shares Out

125,000Employees

Margins

40.93%Gross

26.61%EBITDA

18.20%Operating

16.40%Pre-Tax

15.08%Net

Valuation

26.58P/E

3.34P/B

4.00EV/Sales

17.53EV/EBITDA

28.31P/FCF

Growth (CAGR)

-0.27%Rev 3Yr

6.70%Rev 5Yr

-1.58%Op Inc 3Yr

0.54%Op Inc 5Yr

-1.16%Net Inc 3Yr

1.06%Net Inc 5Yr

Returns

6.47%ROA

13.02%ROE

8.40%ROIC

Financial Health

$9.85BCash & Cash Equivalents

$46.95BNet Debt

106.11%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Thermo Fisher Scientific Inc. trades at a P/E of 26.6 (premium valuation) with solid ROE of 13.0%.”

Ask for details →

Frequently Asked Questions

Thermo Fisher Scientific Inc. (ticker: TMO) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 125,000 employees. Market cap is $178.2B.

The current price is $472.63 with a P/E ratio of 26.58x and P/B of 3.34x.

ROE is 13.02% and operating margin is 18.20%. Annual revenue is $44.6B.